Redmile Group, LLC Catalent, Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q3 2024

A detailed history of Redmile Group, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 595,570 shares of CTLT stock, worth $36.3 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares

595,570

Previous 595,570 -0.0%

Holding current value

$36.3 Million

Previous $33.5 Million 7.72%

% of portfolio

2.36%

Previous 2.18%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $1.98 Million - $2.1 Million	-36,894 Reduced 5.83%	595,570 $33.5 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $19.9 Million - $28 Million	-468,002 Reduced 42.53%	632,464 $35.7 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $1.99 Million - $2.87 Million	-61,700 Reduced 5.31%	1,100,466 $49.4 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $17.6 Million - $37.1 Million	551,862 Added 90.42%	1,162,166 $50.4 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $27.7 Million - $45.3 Million	610,304 New	610,304 $40.1 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $33.9 Million - $44.1 Million	-310,111 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $151,312 - $174,460	-1,508 Reduced 0.48%	310,111 $33.5 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $294,379 - $363,283	-2,900 Reduced 0.92%	311,619 $32.8 Million
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $1.28 Million - $1.57 Million	-14,900 Reduced 4.52%	314,519 $32.7 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $6.09 Million - $7.74 Million	-83,681 Reduced 20.26%	329,419 $28.2 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $4.48 Million - $7.37 Million	-93,200 Reduced 18.41%	413,100 $30.3 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $18.7 Million - $31.9 Million	506,300 New	506,300 $26.3 Million
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $20 Million - $31 Million	-668,850 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $280,840 - $318,850	7,000 Added 1.06%	668,850 $30.5 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $6.63 Million - $7.28 Million	-171,213 Reduced 20.55%	661,850 $27.7 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $25.5 Million - $29.5 Million	685,400 Added 464.17%	833,063 $34.2 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $4.98 Million - $6.15 Million	147,663	147,663 $5.9 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Catalent, Inc. Transaction History